Development of an All-in-One Lentiviral Vector System Based on the Original TetR for the Easy Generation of Tet-ON Cell Lines
Metadata
Show full item recordEditorial
Plos One
Date
2011-08-18Referencia bibliográfica
Benabdellah K, Cobo M, Muñoz P, Toscano MG, Martin F (2011) Development of an All-in-One Lentiviral Vector System Based on the Original TetR for the Easy Generation of Tet-ON Cell Lines. PLoS ONE 6(8): e23734. doi:10.1371/journal.pone.0023734
Sponsorship
Fondo de Investigaciones Sanitarias (FIS) grant: PS09/00340; Junta de Andalucia grants: P09-CTS-04532 and PI0001/2009Abstract
Lentiviral vectors (LVs) are considered one of the most promising vehicles to efficiently deliver genetic information for basic
research and gene therapy approaches. Combining LVs with drug-inducible expression systems should allow tight control
of transgene expression with minimal side effect on relevant target cells. A new doxycycline-regulated system based on the
original TetR repressor was developed in 1998 as an alternative to the TetR-VP16 chimeras (tTA and rtTA) to avoid secondary
effects due to the expression of transactivator domains. However, previously described TetR-based systems required cell
cloning and/or antibiotic selection of tetracycline-responsive cells in order to achieve good regulation. In the present
manuscript we have constructed a dual Tet-ON system based on two lentiviral vectors, one expressing the TetR through the
spleen focus forming virus (SFFV) promoter (STetR) and a second expressing eGFP through the regulatable CMV-TetO
promoter (CTetOE). Using these vectors we have demonstrated that the TetR repressor, contrary to the reverse
transactivator (rtTA), can be expressed in excess to bind and modulate a high number of TetO operons. We have also
showed that this dual vector system can generate regulatable bulk cell lines (expressing high levels of TetR) that are able to
modulate transgene expression either by varying doxycycline concentration and/or by varying the amount of CTetOE vector
genomes per cell. Based on these results we have developed a new all-in-one lentiviral vector (CEST) driving the expression
of TetR through the SFFV promoter and the expression of eGFP through the doxycycline-responsive CMV-TetO operon. This
vector efficiently produced Tet-ON regulatable immortalized (293T) and primary (human mesenchymal stem cells and
human primary fibroblasts) cells. Bulk doxycycline-responsive cell lines express high levels of the transgene with low
amount of doxycycline and are phenotypically indistinct from its parental cells.